Head-To-Head Comparison: Guardian Pharmacy Services (GRDN) versus The Competition

Guardian Pharmacy Services (NYSE:GRDN) is one of 233 publicly-traded companies in the “Healthcare Providers & Services” industry, but how does it contrast to its competitors? We will compare Guardian Pharmacy Services to related companies based on the strength of its analyst recommendations, risk, earnings, institutional ownership, profitability, valuation and dividends.

Profitability

This table compares Guardian Pharmacy Services and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Guardian Pharmacy Services	4.50%	29.97%	16.18%
Guardian Pharmacy Services Competitors	-7.69%	-141.09%	-1.47%

Institutional & Insider Ownership

56.8% of shares of all “Healthcare Providers & Services” companies are held by institutional investors. 33.0% of Guardian Pharmacy Services shares are held by insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Valuation & Earnings

This table compares Guardian Pharmacy Services and its competitors revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Guardian Pharmacy Services	$1.45 billion	$49.22 million	41.60
Guardian Pharmacy Services Competitors	$21.01 billion	$288.54 million	7.36

Guardian Pharmacy Services’ competitors have higher revenue and earnings than Guardian Pharmacy Services. Guardian Pharmacy Services is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

Guardian Pharmacy Services has a beta of 0.06, meaning that its share price is 94% less volatile than the S&P 500. Comparatively, Guardian Pharmacy Services’ competitors have a beta of 0.98, meaning that their average share price is 2% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Guardian Pharmacy Services and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardian Pharmacy Services	0	1	9	0	2.90
Guardian Pharmacy Services Competitors	1852	7707	13270	815	2.55

Guardian Pharmacy Services currently has a consensus price target of $45.57, indicating a potential upside of 6.35%. As a group, “Healthcare Providers & Services” companies have a potential upside of 11.68%. Given Guardian Pharmacy Services’ competitors higher possible upside, analysts clearly believe Guardian Pharmacy Services has less favorable growth aspects than its competitors.

Summary

Guardian Pharmacy Services beats its competitors on 7 of the 13 factors compared.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.